EQR
47
2
KMI
65
-2
DHI
40
3
CPB
37
2
ZBH
45
3
SWKS
56
8
TGT
52
2
OMC
55
-7
FITB
72
2
NEM
69
-2
AZO
46
-2
KMB
33
2
MCD
46
4
GT
39
2
DVN
40
-2
O
35
4
PX
55
2
DTE
42
4
HSY
50
5
PG
43
2
EQR
47
2
KMI
65
-2
DHI
40
3
CPB
37
2
ZBH
45
3
SWKS
56
8
TGT
52
2
OMC
55
-7
FITB
72
2
NEM
69
-2
AZO
46
-2
KMB
33
2
MCD
46
4
GT
39
2
DVN
40
-2
O
35
4
PX
55
2
DTE
42
4
HSY
50
5
PG
43
2
Financhill
Back

CytoMed Therapeutics Ltd. Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Sell
27

GDTC
CytoMed Therapeutics Ltd.

Last Price:
$1.53
Seasonality Move:
-6.92%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%
Sell
27
CytoMed Therapeutics Ltd. (GDTC) is a Sell

Is CytoMed Therapeutics Ltd. a Buy, Sell or Hold?

  • The current CytoMed Therapeutics Ltd. [GDTC] share price is $1.54. The Score for GDTC is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • GDTC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GDTC Stock Price Chart

What is CytoMed Therapeutics Ltd.'s stock price today?

  • The CytoMed Therapeutics Ltd. share price today is $1.54
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GDTC is experiencing slight selling pressure.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

GDTC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 40.05 Sell
Chaikin Money Flow: -430 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.57 - 1.87) Sell
Bollinger Bands (100): (1.71 - 2.19) Sell

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

GDTC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.56 Sell
20-day SMA: 1.68 Sell
50-day SMA: 1.96 Sell
200-day SMA: 2.11 Sell
8-day EMA: 1.56 Sell
20-day EMA: 1.67 Sell
50-day EMA: 1.84 Sell
200-day EMA: 2.07 Sell

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

CytoMed Therapeutics Ltd. Earnings Growth & GDTC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and a decrease next year of $0.00 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

CytoMed Therapeutics Ltd. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):